CN104926734B - 氟班色林的制备方法 - Google Patents
氟班色林的制备方法 Download PDFInfo
- Publication number
- CN104926734B CN104926734B CN201510391692.1A CN201510391692A CN104926734B CN 104926734 B CN104926734 B CN 104926734B CN 201510391692 A CN201510391692 A CN 201510391692A CN 104926734 B CN104926734 B CN 104926734B
- Authority
- CN
- China
- Prior art keywords
- reaction
- preparation
- flibanserin
- piperazine
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510391692.1A CN104926734B (zh) | 2015-07-07 | 2015-07-07 | 氟班色林的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510391692.1A CN104926734B (zh) | 2015-07-07 | 2015-07-07 | 氟班色林的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104926734A CN104926734A (zh) | 2015-09-23 |
CN104926734B true CN104926734B (zh) | 2017-04-05 |
Family
ID=54114190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510391692.1A Active CN104926734B (zh) | 2015-07-07 | 2015-07-07 | 氟班色林的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104926734B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017076213A1 (zh) * | 2015-11-02 | 2017-05-11 | 苏州旺山旺水生物医药有限公司 | 苯并咪唑类化合物、其制备方法及用途 |
CN106749038A (zh) * | 2015-11-25 | 2017-05-31 | 山东诚创医药技术开发有限公司 | 一种氟班色林的制备方法 |
CN105294568B (zh) * | 2015-12-05 | 2017-11-17 | 山东汇海医药化工有限公司 | 一种制备苯并咪唑酮的方法 |
CN106866546A (zh) * | 2015-12-10 | 2017-06-20 | 常州爱诺新睿医药技术有限公司 | 氟班色林或其药学上可接受的盐与药用辅料的固体分散体及其制备方法 |
CN107235913B (zh) * | 2016-03-29 | 2020-07-10 | 苏州科伦药物研究有限公司 | 工业规模高效制造优质氟班色林的方法 |
CN106866582A (zh) * | 2017-01-10 | 2017-06-20 | 广州隽沐生物科技有限公司 | 一种氟班色林中间体的制备方法 |
HU231283B1 (hu) | 2018-08-01 | 2022-09-28 | Richter Gedeon Nyrt | Eljárás a flibanserin többlépéses folyamatos áramú előállítására |
CN109232434A (zh) * | 2018-10-29 | 2019-01-18 | 湖北大学 | 一种合成氟班色林的新方法 |
CN110950821B (zh) * | 2020-02-25 | 2020-05-15 | 湖南九典宏阳制药有限公司 | 左旋西替利嗪的制备方法 |
CN113402467B (zh) * | 2021-06-18 | 2022-05-13 | 山东汇海医药化工有限公司 | 一种氟班色林的合成方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
YU39992B (en) * | 1976-04-02 | 1985-06-30 | Janssen Pharmaceutica Nv | Process for obtaining new piperazine and piperidine derivatives |
IE58370B1 (en) * | 1985-04-10 | 1993-09-08 | Lundbeck & Co As H | Indole derivatives |
US4954503A (en) * | 1989-09-11 | 1990-09-04 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(1-substituted-4-piperazinyl)-1H-indazoles |
IT1251144B (it) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | Derivati del benzimidazolone |
US5883094A (en) * | 1995-04-24 | 1999-03-16 | Pfizer Inc. | Benzimidazolone derivatives with central dopaminergic activity |
AU2002331361B2 (en) * | 2001-08-02 | 2008-06-05 | Sprout Pharmaceuticals, Inc. | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
UA78974C2 (en) * | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
BRPI0311189B8 (pt) * | 2002-05-22 | 2021-05-25 | Boehringer Ingelheim Pharma | composições farmacêuticas contendo polimorfo a de flibanserin, bem como seu uso |
EP2090297A1 (en) * | 2008-02-13 | 2009-08-19 | Boehringer Ingelheim International GmbH | Formulations of flibanserin |
WO2010128516A2 (en) * | 2009-05-04 | 2010-11-11 | Symed Labs Limited | Process for the preparation of flibanserin involving novel intermediates |
-
2015
- 2015-07-07 CN CN201510391692.1A patent/CN104926734B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104926734A (zh) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104926734B (zh) | 氟班色林的制备方法 | |
CN101967145B (zh) | 一种抗血栓药物阿匹沙班的制备方法 | |
CN104447515B (zh) | 制备色瑞替尼的新中间体及其制备方法 | |
CN107365275B (zh) | 高纯度的赛乐西帕 | |
CN105399736A (zh) | 一种依匹哌唑新的制备方法 | |
CN104356092A (zh) | 沃替西汀的制备方法 | |
CN102010407A (zh) | 一种合成达沙替尼的新方法 | |
CN104262264B (zh) | 一种盐酸乌拉地尔的制备工艺 | |
CN109867673B (zh) | 一种合成帕布昔利布的方法 | |
CN106279104A (zh) | 一种制备琥珀酸曲格列汀的工艺改进方法 | |
CN105198821A (zh) | 洛昔替尼的制备方法 | |
CN108276414B (zh) | 一种枸橼酸托法替尼的制备方法 | |
CN103601645A (zh) | 1-(苯乙基氨基)丙烷-2-醇类化合物或其盐的制备方法 | |
CN104311485B (zh) | 一种治疗白血病的药物博舒替尼的制备方法 | |
CN103497146B (zh) | 2-(n-芳甲基哌啶-4-氨基)-4-(取代苯酚)苯环衍生物及其制备方法与应用 | |
CN105693603A (zh) | 改良的马来酸茚达特罗制备工艺 | |
CN106674084A (zh) | 一种2‑异丙基氧基‑5‑甲基‑4‑(哌啶‑4‑基)苯胺二盐酸盐的制备方法 | |
CN105884746B (zh) | 氟马替尼的合成方法 | |
CN102702196B (zh) | 3-甲基-7-氮杂吲哚的合成方法 | |
CN113501795A (zh) | 一种新型重度抑郁症治疗药物伏硫西汀的制备方法 | |
CN107216271A (zh) | 酒石酸匹莫范色林杂质及其制备方法 | |
CN113563285A (zh) | 一种新型重度抑郁症治疗药物伏硫西汀的制备方法 | |
CN102786543A (zh) | 咪唑并[1,2-a]吡啶-6-硼酸频哪醇酯及其衍生物的制备方法 | |
CN102260213A (zh) | 一种托伐普坦的制备方法 | |
CN110437227A (zh) | 一种具有多环桥环骨架的多取代四氢异喹啉及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of flibanserin Effective date of registration: 20190422 Granted publication date: 20170405 Pledgee: Hengfeng Bank Co., Ltd. Zibo Branch Pledgor: Suzhou Lixin Pharmacy Co., Ltd. Registration number: 2019370000083 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200709 Address after: Hu Suzhou high tech Zone of Jiangsu province 215151 City Road No. 21 Tang Guan District Patentee after: SUZHOU LIXIN PHARMACEUTICAL Co.,Ltd. Address before: 215151 No. 21 West Tong Road, hi tech Development Zone, Jiangsu, Suzhou Co-patentee before: Xu Xuenong Patentee before: SUZHOU LIXIN PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201124 Granted publication date: 20170405 Pledgee: Hengfeng Bank Co.,Ltd. Zibo Branch Pledgor: SUZHOU LIXIN PHARMACEUTICAL Co.,Ltd. Registration number: 2019370000083 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |